FindTrial
Sign In

Comparison of effects of remazolam benzenesulfonate and propofol in BIS-guided hysteroscopic anesthesia: a multicentre, randomized, single-blind, noninfertility study

Comparison of effects of remazolam benzenesulfonate and propofol in BIS-guided hysteroscopic anesthesia: a multicentre, randomized, single-blind, noninfertility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048133
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases requiring hysteroscopy

Interventions

Experimental group:Anesthesia with rimazolam
Control Group:Propofol anesthesia

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients who intend to undergo hysteroscopic surgery, voluntarily participate in the study and sign informed consent form; 2.Aged 18 to 65 years; 3.BMI 18.5-30 kg/m2; 4.ASA i-ii grade.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled hypertension; 2. Cardiac dysfunction (ejection fraction 150µmol/L); 6. Preoperative use of benzodiazepines or opioids; 7. Myopathy or diabetes; 8. History of chronic pain, drug or alcohol abuse; 9. Those who refuse to participate in research or do not cooperate with those who cannot communicate.

Design outcomes

Primary

MeasureTime frame
Sedative onset time;—

Countries

China

Contacts

Public ContactLin Jingyan

Affiliated Hospital of North Sichuan Medical College

419931094@qq.com+86 15983771119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026